In the latest randomized, double-blind, placebo-controlled 180-day study with 126 subjects, two dosages of Acujoint™ (250 mg and 175 mg) were evaluated for their effects on joint health, specifically focusing on pain, stiffness, and physical function. The results were impressive, showing statistically significant improvements in knee muscle strength, measured by knee extension, in both Acujoint™ dosage groups when compared to a placebo.

Both dosages of Acujoint™ significantly reduced the intensity of pain and stiffness while producing marked improvements in flexibility and physical function of joints. These results were further validated by significant enhancements in the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index), LAI (Lequesne’s Index), and VAS (Visual Analog Scale) scores. The study concluded that Acujoint™ offers potent anti-inflammatory effects, which could be a promising natural supplement in the treatment of osteoarthritis.

Acujoint™, a polyherbal formulation developed by Aurea Biolabs was used in the clinical study that reinforces its potential as a powerful supplement for the management of joint pain and inflammation, especially in osteoarthritis. The unique patented formulation of natural extracts from Curcuma longa, Boswellia serrata, Kaempferia galanga, and Piper nigrum was developed as nature's bioactive compounds against inflammation, cartilage protection, and improvement of joint health.

The active components in Acujoint™ including curcuminoids, Bio-AKBA, and flavonoids from Kaempferia galanga, were responsible for its anti-inflammatory, and antioxidant effects along with cartilage protection. This innovative study features Acujoint™ as a viable option for those seeking effective, natural support for joint health and pain management.